SecProbe.io

CORRESP
1
filename1.htm

September 12, 2024

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attention: Margaret Sawicki

 Re: Tenon Medical, Inc.

Registration Statement
on Form S-1

File No. 333-281531

Ladies and Gentlemen:

In accordance with Rule 461
of the General Rules and Regulations promulgated under the Securities Act of 1933, as amended (the “Act”), A.G.P./ALLIANCE
GLOBAL PARTNERS, as Sole Placement Agent, hereby joins Tenon Medical, Inc. (the “Company”) in requesting that the Securities
and Exchange Commission take appropriate action to cause the Registration Statement on Form S-1, as amended (the “Registration Statement”),
to become effective as of 5:00 p.m., Eastern Time, on September 12, 2024, or as soon thereafter as is practicable, or at such other time
as the Company or its outside counsel, Sichenzia Ross Ference Carmel LLP, request by telephone that such Registration Statement be declared
effective.

Pursuant to Rule 460 of the
General Rules and Regulations under the Act, the undersigned advises that copies of the Preliminary Prospectus, dated September 9, 2024,
are expected to be distributed to prospective dealers, institutional investors, retail investors and others as appears to be reasonable
to secure adequate distribution of the Preliminary Prospectus.

The Placement Agent is aware
of its obligations under, and confirm that it is complying with, the provisions of Rule 15c2-8 under the Securities Exchange Act of 1934,
as amended, including the delivery requirement contained in such Rule.

    Very truly yours,

    A.G.P./ALLIANCE GLOBAL PARTNERS

    By:
    /s/ Thomas J. Higgins

    Name:
    Thomas J. Higgins

    Title:
    Managing Director